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During the 2012 Princeton Conference, imaging of cerebrovascular disorders was addressed
by a series of topics that incorporated current controversy about advanced modalities for
evaluation of patients with acute ischemic stroke and also emerging, cutting-edge
technologies on tissue metabolism and cerebrovascular reactivity.
Howard Rowley reviewed the role of multimodal CT and MRI, including vascular and
perfusion/penumbral imaging.1 Patient selection for IV thrombolytic and endovascular
stroke treatments outside of standard time windows is not the only reason to perform
advanced neuroimaging. Indeed, there are numerous uses of vascular and perfusion/
penumbral imaging in the evaluation of cerebrovascular disorders. Vascular and perfusion/
penumbral imaging can identify patients at high early risk of stroke after transient ischemic
attacks. They can prognosticate outcome and guide disposition decisions, such as the need
for ICU admission, or frequency of neurological monitoring.
Weili Lin stressed that cerebral oxygen metabolism plays a critical role in maintaining
normal brain function.2 Abnormalities in oxygen metabolism occur in various
neuropathologic conditions, such as ischemic stroke, cerebral trauma, cancer, Alzheimer
disease, and shock. Therefore, the ability to measure tissue oxygenation and oxygen
metabolism quantitatively is essential to the understanding of pathophysiology and treatment
of various diseases. He described a novel imaging method using blood oxygenation level–
dependent contrast to measure tissue oxygenation and oxygen metabolism, and explained
how this approach can be used to select patients with acute ischemic stroke for
revascularization.
David Mikulis described an imaging method to measure cerebrovascular reactivity as an
indicator of cerebral hemodynamics.3 In adults with cerebrovascular disease, impaired
cerebrovascular reactivity has been shown to be associated with an increased risk of stroke.
Copyright © 2013 American Heart Association, Inc. All rights reserved.
Correspondence to Max Wintermark, MD, Department of Radiology, Neuroradiology Division, University of Virginia, PO Box
800170, 1215 Lee St, Charlottesville, VA 22908-0170. max.wintermark@virginia.edu.
NIH Public Access
Author Manuscript
Stroke. Author manuscript; available in PMC 2014 September 06.
Published in final edited form as:
Stroke. 2013 June ; 44(6 0 1): S52. doi:10.1161/STROKEAHA.112.680314.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
The degree of impairment of the cerebrovascular reactivity is also related to the burden of
chronic microvascular disease, and assessing cerebrovascular reactivity can be used to
quantify the results of revascularization therapies.
Thilo Hölscher, presented an emerging therapeutic modality called MRI-guided focused
ultrasound, a new stereotactic technique, that uses high-intensity focused ultrasound to
mechanically enhance clot lysis within the proximal intracranial arteries.4 MRI allows for
precise intraprocedural localization of the targeted clot and real-time monitoring of such
sonothrombolysis.
These presentations generated a rich and interesting discussion about the pivotal role of
imaging in various cerebrovascular disorders, to streamline diagnosis and therapy, while
discerning key pathophysiology of cerebral ischemia. This session underscored the role of
stroke imaging in 2012 as an integral component of therapeutic strategies and avenue for
future translational research.
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